MK-6072

null · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-6072, covering 2016-12-15 to 2016-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001) [Phase 3]

See pricing